Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology company has $462.6 million in cash and equivalents, enough runway to fund ...
As access to safe abortion services remains restricted, the issue in Indonesia mainly centered on illegal providers and unregulated abortion pills.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results